The Allergome e-Newsletter
October 2012
Summary of new data published and added to the Allergome Database:
New Allergenic Molecules in the Allergome Database:
Bla g 3 (1) Bla g 3.0101 (1) Gly m 7 (1) Gly m 7.0101 (1) Por p 1 (1) Por p 2 (1)
Allergenic Molecules added or modified in the IUIS List:
Bla g 3 (1) Bla g 3.0101 (1) Gly m 7.0101 (1)
Allergenic Molecules with new REAGENTS available:
None
Bla g 3 (1) Bla g 3.0101 (1) Gly m 7 (1) Gly m 7.0101 (1) Por p 1 (1) Por p 2 (1)
Allergenic Molecules added or modified in the IUIS List:
Bla g 3 (1) Bla g 3.0101 (1) Gly m 7.0101 (1)
Allergenic Molecules with new REAGENTS available:
None
Relevant new data on established Allergenic Molecules:
Biochemistry / Structure / Function
Ara h 1 (3) Ara h 10 (1) Ara h 11 (1) Ara h 15 (1) Ara h 2 (1) Ara h 3 (2) Ara h 5 (1) Ara h 6 (1) Ara h 7 (1) Ara h 8 (1) Ara h 9 (1) Ara h Agglutinin (1) Cyn d 4 (1) Hom s LF (1) Hom s/Mus m Cetuximab (1) Hom s/Mus m Cetuximab (Gal-Gal) (1) Hom s/Mus m Trastuzumab (1) Pers a 1 (1) Pers a 4 (1) Phl p 4 (1) Por p 1 (1) Por p 2 (1) Pru p 7 (1) Pru p 7.0101 (1) Tal ac (1) Tha p 2 (1) Tha p 2.0101 (1) Vit v 5 (1) Vit v TLP (1)
Molecular Biology
Tha p 2 (1) Tha p 2.0101 (1) Vit v 5 (1) Vit v TLP (1)
Immunochemistry / Allergenicity
Ara h 1 (2) Ara h 3 (1) Bet v 1 (1) Cyn d 4 (1) Hom s/Mus m Rituximab (1) Por p 1 (1) Por p 2 (1) Pru p 3 (1) Pru p 7 (1) Pru p 7.0101 (1) Tha p 2 (1) Tha p 2.0101 (1)
Immune-mechanisms / Genetics
Ara h 2 (1) Bet v 1 (1)
Detection - Indoor Environment
None
Detection - Outdoor Environment <a href="https://www.timereps.org/">best replica watches</a>
None
Detection - Source Extracts, Food Products, Drug Preparations
Ara h 1 (2) Ara h 10 (1) Ara h 11 (1) Ara h 15 (1) Ara h 2 (1) Ara h 3 (2) Ara h 5 (1) Ara h 6 (1) Ara h 7 (1) Ara h 8 (1) Ara h 9 (1) Ara h Agglutinin (1) Der p 1 (2) Pru p 3 (1) Pru p 7 (1) Pru p 7.0101 (1) Tal ac (1)
Detection - Allergy Diagnostic and Immunotherapeutic Products
Bet v 1 (1) Lol p 1 (1) Lol p 5 (1) Phl p 5 (1)
Detection - Source Tissues
Vit v 5 (1) Vit v TLP (1)
Detection - Body Biodistribution
None
Epidemiology
None
Diagnosis
Ara h 1 (2) Ara h 2 (1) Ara h 3 (1) Ara h 8 (1) Bet v 1 (1) Bos d 4 (2) Bos d 5 (3) Bos d 6 (1) Bos d 8 (3) Bos d Gelatin (1) Can f 1 (1) Der p 1 (1) Fel d 1 (1) Hom s Glucocerebrosidase (1) Hom s Glucosidase (1) Hom s/Mus m Cetuximab (1) Hom s/Mus m Infliximab (1) Hom s/Mus m Natalizumab (1) Hom s/Mus m Rituximab (2) Pru p 3 (2) Pru p 7 (1) Pru p 7.0101 (1) Sus s Gelatin (1) Tri a 14 (1) Tri a 19 (1) Tri a 20 (1) Tri a 26 (1) Tri a alpha_Gliadin (1) Tri a beta_Gliadin (1) Tri a Gliadin (1) Ves v 1 (1) Ves v 5 (1)
Immunotherapy
Fel d 1 (1) Hom s Glucocerebrosidase (1)
Experimental Model - Allergic Immune Response
Ara h Agglutinin (1) Cry j 1 (1) Cry j 2 (1) Der p 2 (1) Gal d 2 (10) Hom s LF (1) Tri a Gliadin (1)
Experimental Model - Conjunctival Contact-induced Diseases
None
Experimental Model - Ingestion-induced Diseases
Gal d 2 (1)
Experimental Model - Inhalant-induced Diseases
Der p 2 (1) Gal d 2 (22)
Experimental Model - Injection-induced Diseases
None
Experimental Model - Skin-induced Diseases
Tri a Gliadin (1)
Allergic Diseases in Animals
None
Review, Editorial, Report Citations, Other Resources
Amb a 1 (1) Ara h 1 (1) Ara h 2 (1) Ara h 3 (1) Bet v 1 (1) Bos d 4 (1) Bos d 7 (1) Bos d 8 (1) Bos d LF (1) Can f 1 (1) Cor a 1 (1) Der f 1 (1) Der p 10 (1) Esc c Asparaginase (1) Fel d 1 (1) Gal d 1 (1) Gal d 2 (4) Gal d 3 (1) Gal d 4 (1) Gal d 5 (1) Hom s Adalimumab (1) Hom s Etanercept (1) Hom s Glucosidase (1) Hom s/Mus m Basiliximab (1) Hom s/Mus m Cetuximab (2) Hom s/Mus m Infliximab (1) Hom s/Mus m Natalizumab (1) Hom s/Mus m Omalizumab (1) Hom s/Mus m Palivizumab (1) Hom s/Mus m Rituximab (2) Hom s/Mus m Tocilizumab (1) Hom s/Mus m Trastuzumab (2) Mus m Muromonab (1) Pen a 1 (1) Pen m 1 (1) Phl p 1 (2) Phl p 12 (1) Phl p 4 (1) Phl p 5 (3) Phl p 7 (1) Pru p 3 (1) Tri a 19 (1)
Ara h 1 (3) Ara h 10 (1) Ara h 11 (1) Ara h 15 (1) Ara h 2 (1) Ara h 3 (2) Ara h 5 (1) Ara h 6 (1) Ara h 7 (1) Ara h 8 (1) Ara h 9 (1) Ara h Agglutinin (1) Cyn d 4 (1) Hom s LF (1) Hom s/Mus m Cetuximab (1) Hom s/Mus m Cetuximab (Gal-Gal) (1) Hom s/Mus m Trastuzumab (1) Pers a 1 (1) Pers a 4 (1) Phl p 4 (1) Por p 1 (1) Por p 2 (1) Pru p 7 (1) Pru p 7.0101 (1) Tal ac (1) Tha p 2 (1) Tha p 2.0101 (1) Vit v 5 (1) Vit v TLP (1)
Molecular Biology
Tha p 2 (1) Tha p 2.0101 (1) Vit v 5 (1) Vit v TLP (1)
Immunochemistry / Allergenicity
Ara h 1 (2) Ara h 3 (1) Bet v 1 (1) Cyn d 4 (1) Hom s/Mus m Rituximab (1) Por p 1 (1) Por p 2 (1) Pru p 3 (1) Pru p 7 (1) Pru p 7.0101 (1) Tha p 2 (1) Tha p 2.0101 (1)
Immune-mechanisms / Genetics
Ara h 2 (1) Bet v 1 (1)
Detection - Indoor Environment
None
Detection - Outdoor Environment <a href="https://www.timereps.org/">best replica watches</a>
None
Detection - Source Extracts, Food Products, Drug Preparations
Ara h 1 (2) Ara h 10 (1) Ara h 11 (1) Ara h 15 (1) Ara h 2 (1) Ara h 3 (2) Ara h 5 (1) Ara h 6 (1) Ara h 7 (1) Ara h 8 (1) Ara h 9 (1) Ara h Agglutinin (1) Der p 1 (2) Pru p 3 (1) Pru p 7 (1) Pru p 7.0101 (1) Tal ac (1)
Detection - Allergy Diagnostic and Immunotherapeutic Products
Bet v 1 (1) Lol p 1 (1) Lol p 5 (1) Phl p 5 (1)
Detection - Source Tissues
Vit v 5 (1) Vit v TLP (1)
Detection - Body Biodistribution
None
Epidemiology
None
Diagnosis
Ara h 1 (2) Ara h 2 (1) Ara h 3 (1) Ara h 8 (1) Bet v 1 (1) Bos d 4 (2) Bos d 5 (3) Bos d 6 (1) Bos d 8 (3) Bos d Gelatin (1) Can f 1 (1) Der p 1 (1) Fel d 1 (1) Hom s Glucocerebrosidase (1) Hom s Glucosidase (1) Hom s/Mus m Cetuximab (1) Hom s/Mus m Infliximab (1) Hom s/Mus m Natalizumab (1) Hom s/Mus m Rituximab (2) Pru p 3 (2) Pru p 7 (1) Pru p 7.0101 (1) Sus s Gelatin (1) Tri a 14 (1) Tri a 19 (1) Tri a 20 (1) Tri a 26 (1) Tri a alpha_Gliadin (1) Tri a beta_Gliadin (1) Tri a Gliadin (1) Ves v 1 (1) Ves v 5 (1)
Immunotherapy
Fel d 1 (1) Hom s Glucocerebrosidase (1)
Experimental Model - Allergic Immune Response
Ara h Agglutinin (1) Cry j 1 (1) Cry j 2 (1) Der p 2 (1) Gal d 2 (10) Hom s LF (1) Tri a Gliadin (1)
Experimental Model - Conjunctival Contact-induced Diseases
None
Experimental Model - Ingestion-induced Diseases
Gal d 2 (1)
Experimental Model - Inhalant-induced Diseases
Der p 2 (1) Gal d 2 (22)
Experimental Model - Injection-induced Diseases
None
Experimental Model - Skin-induced Diseases
Tri a Gliadin (1)
Allergic Diseases in Animals
None
Review, Editorial, Report Citations, Other Resources
Amb a 1 (1) Ara h 1 (1) Ara h 2 (1) Ara h 3 (1) Bet v 1 (1) Bos d 4 (1) Bos d 7 (1) Bos d 8 (1) Bos d LF (1) Can f 1 (1) Cor a 1 (1) Der f 1 (1) Der p 10 (1) Esc c Asparaginase (1) Fel d 1 (1) Gal d 1 (1) Gal d 2 (4) Gal d 3 (1) Gal d 4 (1) Gal d 5 (1) Hom s Adalimumab (1) Hom s Etanercept (1) Hom s Glucosidase (1) Hom s/Mus m Basiliximab (1) Hom s/Mus m Cetuximab (2) Hom s/Mus m Infliximab (1) Hom s/Mus m Natalizumab (1) Hom s/Mus m Omalizumab (1) Hom s/Mus m Palivizumab (1) Hom s/Mus m Rituximab (2) Hom s/Mus m Tocilizumab (1) Hom s/Mus m Trastuzumab (2) Mus m Muromonab (1) Pen a 1 (1) Pen m 1 (1) Phl p 1 (2) Phl p 12 (1) Phl p 4 (1) Phl p 5 (3) Phl p 7 (1) Pru p 3 (1) Tri a 19 (1)
New Allergenic Sources from the Literature:
Morella rubra (1)
This Allergome e-Newsletter is automatically generated during the data entry and
sent to you on November 21, 2024 09:30 +1GMT
Contact us for any further information.
The Allergome Administrator
Adriano Mari, MD
Via Malipiero 28
04100 Latina, Italy
tel +39 3388837352
http://www.allergome.org
adriano.mari@allergome.org
allergome@allergome.org